Batool A Haider
About Batool A Haider
Batool A. Haider is the Director of Health Economics and Outcomes Research at Alkermes in the Greater Boston Area, with extensive experience in medical research and public health.
Current Role at Alkermes
Batool A Haider is currently the Director of Health Economics and Outcomes Research in the Medical Affairs department at Alkermes. Based in the Greater Boston Area, her role involves leading initiatives to generate real-world evidence for pharmaceutical products. This includes both retrospective and prospective observational studies to gather data from various sources such as administrative claims and electronic medical records.
Previous Experience at Alkermes
Before her current role, Batool A Haider served as the Associate Director of Health Economics and Outcomes Research at Alkermes from 2018 to 2019. In this position, she contributed to multiple projects aimed at generating real-world evidence, thereby aligning healthcare outcomes with the company's strategic objectives.
Work at Analysis Group
From 2014 to 2018, Batool A Haider was an Associate at the Analysis Group in the Greater Boston Area. During her four-year tenure, she was involved in conducting systematic literature reviews, meta-analyses, network meta-analyses, and meta-regression. Her work contributed to numerous projects that provided valuable insights into various therapeutic areas such as oncology, neurology, and infectious diseases.
Educational Background
Batool A Haider holds a Doctor of Science degree from the Harvard T.H. Chan School of Public Health, earned between 2009 and 2014. She also achieved a Master's degree from the same institution from 2009 to 2012. Prior to her studies at Harvard, Batool completed her Master of Science at Aga Khan University and a Bachelor of Medicine, Bachelor of Surgery (M.B.B.S) at Dow Medical College.
Research and Publications
Batool A Haider has co-authored manuscripts published in leading peer-reviewed scientific journals. She specializes in generating real-world evidence through retrospective and prospective observational studies. Her research has been presented at major pharmacoepidemiology and health outcomes conferences, covering a wide range of therapeutic areas, including oncology, rheumatology, neurology, and infectious diseases.